The FDA has approved the following new indications:
- Seroquel XR (quetiapine fumarate) extended-release tablets -- for maintenance treatment of schizophrenia in adult patients
- Nexavar (sorafenib) tablets - for the treatment of patients with unresectable hepatocellular carcinoma
- Avalide (irbesartan/hydrochlorothiazide) - for initial use in patients with hypertension who are likely to need multiple drugs to achieve blood pressure goals
- Abilify (aripiprazole) - as adjunctive treatment to antidepressant therapy in adults with major depressive disorder.
No comments:
Post a Comment